Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients

BACKGROUND: Hydroxychloroquine (HCQ) is a cornerstone therapy for systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). However, reports of its use and subsequent fatal arrhythmias in patients with Coronavirus disease 19 (COVID-19) have raised concern regarding its cardiovascular (CV) sa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Res Sq
Autors principals: Park, Elizabeth, Giles, Jon T., Perez-Recio, Thania, Pina, Paloma, Depender, Christopher, Gartshteyn, Yevgeniya, Askanase, Anca, Bathon, Joan, Geraldino-Pardilla, Laura
Format: Artigo
Idioma:Inglês
Publicat: American Journal Experts 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8259909/
https://ncbi.nlm.nih.gov/pubmed/34230925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-650818/v1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars